Press Release

View printer-friendly version Back

Lantheus Holdings, Inc. to Present at 2017 Cantor Fitzgerald Global Healthcare Conference

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Sep. 13, 2017-- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), today announced that Mary Anne Heino, President and Chief Executive Officer, and Jack Crowley, Chief Financial Officer, will present at the 2017 Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26 at 1:40 p.m. Eastern Time. The conference will be held at the InterContinental New York Barclay Hotel in New York City.

To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for 30 days following the live presentation.

About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus Holdings, Inc. is the parent company of LMI, a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. LMI provides a broad portfolio of products, including the echocardiography contrast agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. The Company is headquartered in North Billerica, Massachusetts with offices in Puerto Rico and Canada. For more information, visit www.lantheus.com.

Source: Lantheus Holdings, Inc.

Lantheus Holdings, Inc.
Meara Murphy, 978-671-8508
Director, Investor Relations & Corporate Communications
or
Gary Santo, 978-671-8960
Head of Capital Markets & Investor Relations